Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Aminophylline × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Cyclophosphamide 2672 Cisplatin 2637 Carboplatin 2447 Radiotherapy 2256 Paclitaxel 2245 Gemcitabine 2114 pembrolizumab 1954 Docetaxel 1856 Bevacizumab 1768 Fluorouracil 1536 Capecitabine 1504 Oxaliplatin 1426 Dexamethasone 1328 Nivolumab 1253 Doxorubicin 1246 Rituximab 1233 Etoposide 1128 Magnetic Resonance Spectroscopy 1054 Irinotecan 1034 Leucovorin 1019 Cytarabine 965 Drug Therapy 891 fludarabine 888 Pemetrexed 883 Vincristine 792 Lenalidomide 783 Prednisone 778 Cetuximab 768 Filgrastim 764 Specimen Handling 759

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01240824 2014-04-14

BCG

University of Virginia

Phase EARLY_PHASE1 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡